drugset / Trial / NCT02304588

Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot

NCT02304588

Phase 1 Unknown 20 enrolled Chinese PLA General Hospital
NaSingle-groupOpen-labelTreatment

Summary

Mesenchymal stem cells with multidirectional differentiation potential,autologous stem cell transplantation into ischemic foot, make its differentiation to form new blood capillary, improve and restore the local blood flow.

Timeline

Start
2013-01
Primary completion
2015-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 20 ml
Subject mesenchymal stem cells Cell therapy 1e+07 cells
Subject mesenchymal stem cells Cell therapy 2e+07 cells

Indications